Sensitive ARV resistance tests detect no dapivirine-associated resistance among women using dapivirine vaginal ring in ASPIRE

10/24/2018

 

Researchers present additional evidence on the safety of the dapivirine vaginal ring for HIV prevention in women

10/23/2018

 

Women facing intimate partner violence were less likely to use vaginal ring in ASPIRE

10/18/2016

 

Dapivirine ring did not confer drug resistance among women who acquired HIV in ASPIRE

10/18/2016

 

HOPE open-label study of vaginal ring for preventing HIV begins for former ASPIRE participants

07/18/2016

 

Used consistently, monthly vaginal ring may be highly effective against HIV in women, suggest new analyses from ASPIRE

07/18/2016

 

Dapivirine vaginal ring helped protect women against HIV in ASPIRE Phase III trial

02/22/2016

  

Researchers complete ASPIRE Phase III trial of the dapivirine vaginal ring for HIV prevention in women; results are expected early 2016

06/29/2015

 

ASPIRE Phase III trial of a vaginal ring for HIV prevention completes enrollment of 2,629 women

06/26/2014

 

Phase III Trial of Dapivirine Ring Begins in Africa: ASPIRE testing new HIV prevention approach for women

07/24/2012